Key Points
- Insider buying: CVS Group director Joanne Shaw purchased 1,592 shares at GBX 1,287 each, totaling £20,489.04.
- Analyst outlook: Four analysts rate the stock Buy and one rates it Hold, producing a consensus “Moderate Buy” rating and an average price target of GBX 1,720.
- Stock profile: Shares opened at GBX 1,302, while the company reported a market capitalization of approximately £891 million and a 12-month trading range of GBX 1,062 to GBX 1,648.
CVS Group plc (LON:CVSG - Get Free Report) insider Joanne Shaw acquired 1,592 shares of the stock in a transaction on Monday, August 10th. The shares were bought at an average price of GBX 1,287 per share, for a total transaction of £20,489.04.
CVS Group Trading Up 0.9%
Shares of CVS Group stock opened at GBX 1,302 on Wednesday. The company has a quick ratio of 0.90, a current ratio of 1.07 and a debt-to-equity ratio of 92.34. CVS Group plc has a 12-month low of GBX 1,062 and a 12-month high of GBX 1,648. The company has a market capitalization of £891.13 million, a price-to-earnings ratio of 18.90, a PEG ratio of 1.77 and a beta of 1.07. The firm's 50-day moving average price is GBX 1,236.49 and its two-hundred day moving average price is GBX 1,240.98.
CVS Group announced that its board has initiated a stock buyback program on Tuesday, May 26th that permits the company to buyback 0 outstanding shares. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback programs are often a sign that the company's management believes its stock is undervalued.
Analyst Ratings Changes
CVSG has been the subject of several recent analyst reports. Berenberg Bank restated a "buy" rating and set a GBX 2,000 target price on shares of CVS Group in a research note on Thursday, July 23rd. Jefferies Financial Group upped their price objective on CVS Group from GBX 1,350 to GBX 1,400 and gave the stock a "hold" rating in a research report on Friday, July 31st. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and issued a GBX 1,700 price objective on shares of CVS Group in a research note on Monday, July 27th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, CVS Group presently has a consensus rating of "Moderate Buy" and a consensus price target of GBX 1,720.
Get Our Latest Stock Report on CVSG
About CVS Group
(
Get Free Report)
CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.
The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
